Clinical Trial Update: Trial of High Dose Topotecan With Carboplatin in Patients With Relapsed Ovarian Carcinoma [Phase 1]

View source ↗

Summary

A Phase 1 trial of high-dose topotecan with carboplatin in relapsed ovarian cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Topotecan (topotecan)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Ovarian Cancer, Relapses | Phase 1 | Status: TERMINATED